Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127053781 | 12705378 | 1 | I | 20160412 | 20160414 | 20160901 | 20160901 | PER | US-ASTRAZENECA-2016SE41532 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127053781 | 12705378 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 20 | MG | CAPSULE | BID | |||||
| 127053781 | 12705378 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 20 | MG | CAPSULE | BID | |||||
| 127053781 | 12705378 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 20 | MG | CAPSULE | QD | |||||
| 127053781 | 12705378 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 20 | MG | CAPSULE | QD | |||||
| 127053781 | 12705378 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 20 | MG | CAPSULE | BID | |||||
| 127053781 | 12705378 | 6 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 21153 | 20 | MG | CAPSULE | BID | |||||
| 127053781 | 12705378 | 7 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | OMEPRAZOLE RX, 20 MG DAILY | U | U | 0 | ||||||||
| 127053781 | 12705378 | 8 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | OMEPRAZOLE RX, 20 MG DAILY | U | U | 0 | ||||||||
| 127053781 | 12705378 | 9 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | |||||||||
| 127053781 | 12705378 | 10 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | U | U | 0 | |||||||||
| 127053781 | 12705378 | 11 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127053781 | 12705378 | 1 | Dyspepsia |
| 127053781 | 12705378 | 2 | Gastrooesophageal reflux disease |
| 127053781 | 12705378 | 3 | Dyspepsia |
| 127053781 | 12705378 | 4 | Gastrooesophageal reflux disease |
| 127053781 | 12705378 | 5 | Dyspepsia |
| 127053781 | 12705378 | 6 | Gastrooesophageal reflux disease |
| 127053781 | 12705378 | 7 | Dyspepsia |
| 127053781 | 12705378 | 8 | Gastrooesophageal reflux disease |
| 127053781 | 12705378 | 9 | Dyspepsia |
| 127053781 | 12705378 | 10 | Gastrooesophageal reflux disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127053781 | 12705378 | Abdominal pain upper | |
| 127053781 | 12705378 | Adverse event | |
| 127053781 | 12705378 | Dyspepsia | |
| 127053781 | 12705378 | Flatulence | |
| 127053781 | 12705378 | Intentional product misuse | |
| 127053781 | 12705378 | Off label use | |
| 127053781 | 12705378 | Pain | |
| 127053781 | 12705378 | Therapeutic response delayed |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127053781 | 12705378 | 3 | 20160401 | 20160408 | 0 | |
| 127053781 | 12705378 | 4 | 20160401 | 20160408 | 0 | |
| 127053781 | 12705378 | 5 | 20160412 | 0 | ||
| 127053781 | 12705378 | 6 | 20160412 | 0 | ||
| 127053781 | 12705378 | 11 | 20160413 | 0 |